To test the possibility that variations in macrophage lipoprotein lipase (LPL) secretion may constitute one of the hereditary components of atherosclerosis, we evaluated LPL gene expression and secretion in macrophages harvested from inbred mouse strains differing in their susceptibility to the diet-induced development of atherosclerosis. Inflammatory peritoneal macrophages harvested from atherosclerosissusceptible C57BL/6J mice showed twofold to threefold higher basal LPL mass, activity, and mRNA levels than those isolated from atherosclerosis-resistant C3H/HeN mice. We determined LPL secretion and gene expression in the susceptible C57BL/6J (B), resistant A/J (A), and AxB/BxA recombinant inbred strains of mice typed as atherosclerosis resistant (A-like) or atherosclerosis susceptible (B-like). Macrophage LPL secretion and mRNA expression were twofold higher in the susceptible C57BL/6J (B) mice than in the resistant A/J (A) mice. Significantly higher LPL secretion, activity, and gene expression were found in recombinant inbred mouse strains that typed B-like than in those typed A-like. These results indicate that susceptibility to atherosclerosis is associated in inbred mouse strains with high LPL secretion and mRNA levels, whereas lower LPL secretion and mRNA expression are observed in atherosclerosis-resistant mice. These observations suggest a contributive role for LPL in the development of atherosclerosis. (Arteriosclerosis and Thrombosis 1993;13:190-196) 
To test the possibility that variations in macrophage lipoprotein lipase (LPL) secretion may constitute one of the hereditary components of atherosclerosis, we evaluated LPL gene expression and secretion in macrophages harvested from inbred mouse strains differing in their susceptibility to the diet-induced development of atherosclerosis. Inflammatory peritoneal macrophages harvested from atherosclerosissusceptible C57BL/6J mice showed twofold to threefold higher basal LPL mass, activity, and mRNA levels than those isolated from atherosclerosis-resistant C3H/HeN mice. We determined LPL secretion and gene expression in the susceptible C57BL/6J (B), resistant A/J (A), and AxB/BxA recombinant inbred strains of mice typed as atherosclerosis resistant (A-like) or atherosclerosis susceptible (B-like). Macrophage LPL secretion and mRNA expression were twofold higher in the susceptible C57BL/6J (B) mice than in the resistant A/J (A) mice. Significantly higher LPL secretion, activity, and gene expression were found in recombinant inbred mouse strains that typed B-like than in those typed A-like. These results indicate that susceptibility to atherosclerosis is associated in inbred mouse strains with high LPL secretion and mRNA levels, whereas lower LPL secretion and mRNA expression are observed in atherosclerosis-resistant mice. These observations suggest a contributive role for LPL in the development of atherosclerosis. It has been shown that lipoprotein activity is low in normal arteries, which have few macrophages, and increases during progression of the atherosclerotic plaque, which contains large numbers of macrophage-like cells. 3 One mechanism that may lead to foam cell development could be the synthesis and secretion of lipoprotein lipase (LPL) by macrophages. 4 LPL has been identified as a constitutive secretory product of the macrophage. 5 It is a key enzyme in the catabolism of triglyceride-rich lipoproteins into chylomicrons and very low density lipoproteins (VLDLs). By facilitating their uptake, LPL seems to cause an accumulation of cholesteryl esters as well as triglycerides in macrophages. 6 Mice derived from A/J strains have been shown to be resistant to the development of atherosclerosis, whereas the C57BL/6J strain has been shown to be susceptible. 7 Experiments with crossbred and back-crossed mice of the A/J and C57BL/6J strains indicated a polygenic system of inheritance of susceptibility or resistance to the development of atherosclerosis. 8 ' 9 The objective of the present study was to assess the contribution of genetically determined differences in macrophage LPL expression and secretion to the states of susceptibility/resistance to atherosclerosis in different inbred mouse strains.
Methods

Chemicals
Fetal bovine serum (FBS) was purchased from Hyclone Laboratories Inc., Logan, Utah. Dulbecco's minimal essential medium (DMEM) was obtained from ICN Biomedicals, Inc., Costa Mesa, Calif., and supplemented with 10% FBS, 2 mM L-glutamine (ICN), and penicillin-streptomycin (Flow, McLean, Va.). as previously described." Triplicate samples of 10 ^g purified LPL were electrophoresed in 10% sodium dodecyl sulfate-polyacrylamide gel. After completion of the electrophoretic transfer to a nitrocellulose membrane, the membrane was cut into three identical strips. The strips were blocked overnight with phosphate- 
Typing for the Trait of Resistance/Susceptibility
Typing for the trait of resistance/susceptibility to atherosclerosis was done using a modification of the method of Roberts and Thompson. 7 The presence or absence of aortic lesions was the criterion for assignment of experimental animals to one of two phenotypic categories: susceptible or resistant to diet-induced atherosclerosis. The lesions were scored according to number, size, foam cell content, and degree of involvement of the aortic wall to a maximum score of 10.
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Macrophages
Peritoneal exudate macrophages were harvested 4 days after injection of 1 ml thioglycolate or peptone. Cells were plated at a density of 2x 10 6 cells/ml (close to conflueflcy) in DMEM supplemented with 10% FBS (DMEM-FBS). After 2 hours of adherence, the cells were washed and cultured for 18 hours in DMEM-FBS. At the end of this incubation period, supernatants were collected for LPL mass and activity determinations.
RNA Extraction
Ten million macrophages were plated in 35-mm plastic Petri dishes (Falcon, Lincoln Park, N.J.). After 2 hours of adherence, cells were washed and cultured for 18 hours in DMEM-FBS. Macrophages were lysed with guanidine isothiocyanate. Total RNA was purified by centrifugation through a cesium chloride gradient as described by Chirgwin et al. 12 
Northern Blot Analysis
Total RNA (15 fig) was separated on a 1.2% agarose gel containing 2.2 M formaldehyde as previously described. 13 The blots were prehybridized for 18 hours in a prehybridization buffer (Hybridizol, Oncor, Gaithersburg, Md. hybridization with 32 P-deoxycytidine triphosphate (specific activity, approximately 3,000 Ci/mmol; Amersham Corp., Arlington Heights, Ill.)-labeled purified DNA inserts. Hybridization was detected by autoradiography with Kodak X-Omat-AR film (Rochester, N.Y.).
Dot Blot Analysis
Total cellular RNA was applied to nitrocellulose filters at serial dilutions ranging from 3 to 0.01 /ig/dot. After prehybridization, the membrane was hybridized with LPL or actin probes as described above. Relative concentrations of LPL mRNA levels were calculated after quantitative scanning densitometry of the dot blot. The LPL cDNA probe was shown to hybridize only to the relevant LPL mRNA band.
cDNA Inserts
The probe for detection of human LPL was prepared by potymerase chain amplification. cDNA was obtained from total RNA using a reverse-transcription reaction. Two synthetic primers spanning bases 255-287 and 1,127-1,148 of the LPL cDNA were used to enzymatically amplify an 872-bp region of the LPL probe. The LPL probe was subsequently purified on a low-melting agarose gel. The probe for transforming growth factor-^ (TGF-B) was kindly provided by Dr. R. Derynck (National Institutes of Health, Bethesda, Md.).
Determination of LPL Activity
LPL activity was assayed according to the method of Nilsson-Ehle and Schotz.
14 Briefly, 100 /il medium was incubated with 100 ul of a substrate mixture containing glycerol tri[9,10(n)-3 H]oleate (New England Nuclear, Boston, Mass.), 1 mg triolein, 2 mg BSA, 0.12 mg lecithin, 16-20% heat-inactivated human or bovine serum, and 16% (vol/vol) glycerol in 0.2 M tris(hydroxymethyl)aminomethane-hydrochloride (pH 8.0). The substrate mixture was incubated for 60 minutes at 37°C. The specific activity of the substrate was 100 disintegrations per minute per nanomole of fatty acid. One unit of enzyme activity was defined as the release of 1 nmol fatty acid per minute. Each sample was tested in quadruplicate.
Determination of LPL Immunoreactive Mass
Medium LPL immunoreactive mass was measured by enzyme-linked immunosorbent assay (ELISA) using affinity-purified antibodies specific for LPL according to the techniques previously described 15 ' 16 with some modifications. In brief, 1 jig/well purified antibody against bovine LPL was absorbed in 96-well plates (Immulon II, Dynatech or Costar) and incubated overnight with different dilutions of the sample (in PBS or 0.154 M NaCl) or murine LPL standards. The wells were then washed with PBS and 0.05% Tween 20, and the affinitypurified anti-LPL antibody was added. After further washing, anti-rabbit IgG-peroxidase was added to the wells and incubated for 3 hours. The peroxidase reaction was developed by adding peroxidase substrate (0.3 mg/ml o-phenylenediamine and 0.012% hydrogen peroxide in 0.1 M citrate, pH 4.5). The reaction was stopped with 25 ^tl of 4 M sulfuric acid, and results were read in an ELISA plate reader (Dynatech).
Protein Determination Assay
Peritoneal macrophages were plated at a concentration of lxlO 6 cells/ml. After an 18-hour incubation period, the cells were lysed with 0.5N NaOH and the total protein concentrations were determined by a protein assay kit (Biorad, Mississauga, Canada).
Statistical Analysis
Statistical analysis was determined by the two-tailed Student's / test.
Results
Macrophage LPL Mass, Activity, and Gene Expression in C57BL/6J and C3H/HeN Inbred Mouse Strains
We evaluated the LPL mass, activity, and mRNA expression in thioglycolate-elicited macrophages of C57BL/6J and C3H/HeN inbred mouse strains, which show susceptibility or resistance to the development of atherosclerosis, respectively (Figure 2) . Determination of LPL mass indicated significantly more (p<0.01) LPL in the C57BL/6J mice than in the C3H/HeN mice ( Figure 2A) . Similarly, LPL activity was found to be significantly higher (/?<0.02) in C57BL/6J mice than in the C3H/HeN mice ( Figure 2B ). Finally, peritoneal macrophages of C57BL/6J mice were found to constitutively express higher LPL mRNA levels than the C3H/ HeN mice macrophages (C57BL/6J, 2.6±0.08 versus C3H/HeN, 1.0±0.04; p<0.001; Figure 2C ). The observed difference in LPL expression was specific for this gene, since the macrophage expression of TGF-/3 was similar in both mouse strains ( Figure 2C) . We also measured the activity and mass of LPL in resident peritoneal macrophage populations harvested from mice of either inbred strain and we observed similar differences in LPL levels between C57BL/6J and C3H/ HeN mice (data not shown).
Macrophage LPL Mass, Activity, and mRNA Expression in C57BL/6J and A/J Inbred Mouse Strains
The results of LPL secretion in C57BL/6J and A/J mice are presented in Figure 3A . Macrophages harvested from the atherosclerosis-susceptible C57BL/6J mice secreted significantly higher (p<0.01) LPL mass than those isolated from the resistant A/J mice. LPL activity was also found to be significantly higher (/?<0.001) in macrophages harvested from the susceptible mice than in cells isolated from the resistant mice ( Figure 3B) . Results of dot blot analysis of LPL mRNA expression in these two strains ( Figure 3C ) showed that LPL mRNA levels were 2.5-fold higher in the C57BL/6J mice compared with those observed in the A/J mice (3.9±0.2 versus 1.6±0.2, respectively; p<0.01). Figure 4 shows the LPL mass determined for the RI mice showing the phenotype of resistance to atherosclerosis as the A/J parent (A-like) or the phenotype of susceptibility to atherosclerosis as the C57BL/6J parent (B-like). LPL secretion was much higher in the group of RI typed B-like than in that of RI typed A-like (6.2±0.4 versus 2.8±0.2 ng/jzg protein per ml, respectively;/><0.01; Figures 4A and 4B and Table 1 ). Measurement of LPL activity also indicated a difference between the two groups of mice (3.65 ±0.48 versus 1.24 ±0.27 nmol fatty acids • min • yug protein" 1 • ml~l;p<0.01; Figures 5A and 5B). LPL mRNA expression as analyzed by dot blot analysis in RI mouse strains is presented in Figure 6 . As shown, the group of RI strains typed susceptible to atherosclerosis was found to have a twofold to threefold higher LPL mRNA expression than that observed in the group of RI strains that typed resistant to atherosclerosis.
Macrophage LPL Mass, Activity, and mRNA Expression in RI Strains Derived From A/J and C57BL/6J Mice
Discussion
Variation among many genes is known to contribute to the hereditary component in atherosclerosis. Extensive studies of plasma lipoproteins have shown that elevated low density lipoproteins (LDLs) and elevated VLDLs are positively correlated with increased risk for ischemic vascular and coronary heart disease in humans. 17 Supporting these data, previous studies have identified structural genes for lipoproteins and apolipoproteins that determine murine susceptibility to atherosclerosis. 18 -20 The finding that macrophages secrete LPL, 5 possibility that the macrophage may play a role in the atherogenic process. One of the earliest events observed in experimental atherosclerosis is the adherence of circulating monocytes to arterial endothelial cells. 21 Circulating monocytes penetrate between endothelial cells and enter the intima. Since LPL, by hydrolyzing triglycerides, generates remnant lipoproteins that are taken up avidly by macrophages, 22 it may facilitate the macrophage conversion into foam cells and may consequently promote the atherogenic process. Several lines of evidence support the possibility of a role for LPL in the atherogenic process. Previous results have shown that LPL activity was low in normal arteries and increased during the progression of atherosclerotic lesions. 3 Furthermore, it has recently been reported that macrophages express LPL, both mRNA and protein, in atherosclerotic lesions in vivo. 23 Major histological and biochemical features of foam cells can be reproduced in vitro by incubating mouse peritoneal macrophages in the presence of high density lipoproteins. Mouse peritoneal macrophages take up acetylated LDLs and VLDLs by receptor-mediated endocytosis, hydroryze the cholesteryl esters, and then reesterify the cholesterol in the cytoplasm. The reesterified cholesterol accumulates as cytoplasmic droplets that resemble the droplets seen in foam cells of atherosclerotic lesions. There is evidence to suggest that a cholesteryl ester cycle like that which occurs in isolated mouse peritoneal macrophages may also take place in vivo in foam cells of atherosclerotic lesions. 24 - 25 These observations suggest that peritoneal macrophages may serve as a model for intimal macrophages.
LPL expression and genetic variation have been studied previously in the rodent model. 26 " 28 Since there is an inherited tendency toward the development of atherosclerosis, 29 we tested the possibility that an increase in the constitutive macrophage LPL secretion could be one of the genetically controlled mechanisms involved in the susceptibility to atherosclerosis. We have demonstrated, using inbred mouse strains, that inflammatory peritoneal macrophages isolated from 30 The typing criteria used by the investigators were clearly different; in addition, it is possible that different areas of the aorta were sampled by each investigator for the purpose of scoring atherosclerotic lesions. This is an important variable in the identification of the lesions and possibly an additional source of discrepancy in the typing. The differences detected in LPL gene expression reported in the present article are consistent with the atherosclerosis resistance/susceptibility profile not only of the RI strains of mice but also of several inbred strains of mice, including C3H/HeN, C3H/HeJ, C57BL/6J, and A/J, for which the typing is consistent.
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Since we maintained the mice on a normal chow diet, the difference between susceptible and resistant mice in their macrophage LPL expression represents genetically rather than dietarily induced LPL variations. To test whether diet may alter LPL expression, we also examined LPL expression in macrophages harvested from mice fed a high-fat diet for 10 weeks. We found that a high-cholesterol diet had no effect on LPL gene expression and secretion (data not shown).
Although these results do not prove that peritoneal macrophage LPL levels are causal in atherogenesis, the concordance of the phenotypes of lesion formation and LPL levels may suggest a contributive role of macrophage LPL to the state of susceptibility/resistance to atherosclerosis. Inherited differences in macrophage LPL expression could represent one of the mechanisms by which a high or a low production of LPL is generated in the intima by lesion macrophages. Inherited high LPL expression could contribute to a high local production of LPL in atherosclerotic lesions. This high lipase secretion could facilitate macrophage uptake of lipoproteins by accelerating the degradation of VLDL particles or remnants, thus promoting the atherogenic process.
Alternatively, local regulation of LPL expression may also be achieved by many factors, including tumor necrosis factor, interferon gamma, and colony-stimulating factors that are present in the arterial wall and are known to regulate LPL expression in vitro. 32 -33 In this regard, the close association of T cells with macrophages in the intima is interesting in view of the well-known regulatory interactions between these two cell types.
In summary, we have shown that inbred mouse strains differing in their susceptibility to atherosclerosis present genetically controlled differences in macrophage LPL expression. Our data indicate that susceptibility to atherosclerosis is associated with high LPL expression, whereas resistance is associated with low LPL production. These results are consistent with the view that macrophage LPL expression may constitute one of the inherited components of atherosclerosis. These findings with murine peritoneal macrophages must now be confirmed in human macrophages isolated from atherosclerotic lesions to fully assess the pathophysiological importance of LPL in human atherosclerosis.
